Author

Adrian Nordmark

Observed name: Nordmark, Adrian

Institution: Biovica (Sweden)

Observed institution: Biovica (Sweden)

OpenAlex ID: A5010165112

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

2023 · Mattias Bergqvist, Adrian Nordmark, et al. · Biomarkers · 14

Abstract P5-13-22: Serum thymidine kinase 1 activity (TKa) levels and progression-free survival (PFS) in patients (pts) with hormone receptor positive (HR+) HER2-negative metastatic breast cancer (MBC) on palbociclib (Pb) and endocrine therapy (ET)

2022 · Ciara C O'Sullivan, Jun He, et al. · Cancer Research

Abstract PS5-24: Novel genomic variants and pathways associated with baseline serum thymidine kinase 1 levels in HR-positive HER2-negative MBC patients commencing palbociclib and letrozole

2021 · Ciara C O Sullivan, Krishna R Kalari, et al. · Cancer Research

Regional utveckling i Region Gävleborg : En fallstudie om hur landsbygdskommunerna förhåller sig till den regionala utvecklingsstrategin

2019 · Adrian Nordmark

Storskaliga markinvesteringar i Etiopien, en möjlighet för utveckling?

2018 · Adrian Nordmark

Standardisering av diagnostiska tester genom utveckling av kopplingskemier för sjukdomsspecifika markörer

2016 · Konrad Gras, Julia Giertta Adler, et al. · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Works count: 8

Citation count: 14

H-index: 1

I10-index: 1